Loading…

Efficacy and Safety of Polatuzumab-Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin and Prednisone (Pola-R-CHP) for Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): A Real-World, Multi-Center, Retrospective Cohort Study

Saved in:

Bibliographic Details
Published in:	Blood 2024-11, Vol.144 (Supplement 1), p.3730-3730
Main Authors:	Peiqi, Zhao, Zhao, Shu, Huang, Chen, Wang, Jiesong, Xu, Junqing, Li, Lanfang, Qian, Zhengzi, Li, Wei, Zhou, Shiyong, Qiu, Lihua, Liu, Xianming, Chen, Ying, Jiang, Yanan, Zheng, Yanbin, Chen, Daoguang, Gao, Yuhuan, Zhang, Qingyuan, Zhang, Huilai
Format:	Article
Language:	English
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!